NO324881B1 - Anvendelse av en stamme av Lactobacillus for fremstilling av et medikament for profylakse og/eller behandling av sirkulatoriske sykdommer. - Google Patents

Anvendelse av en stamme av Lactobacillus for fremstilling av et medikament for profylakse og/eller behandling av sirkulatoriske sykdommer. Download PDF

Info

Publication number
NO324881B1
NO324881B1 NO20000268A NO20000268A NO324881B1 NO 324881 B1 NO324881 B1 NO 324881B1 NO 20000268 A NO20000268 A NO 20000268A NO 20000268 A NO20000268 A NO 20000268A NO 324881 B1 NO324881 B1 NO 324881B1
Authority
NO
Norway
Prior art keywords
lactobacillus
strain
fibrinogen
prophylaxis
treatment
Prior art date
Application number
NO20000268A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000268L (no
NO20000268D0 (no
Inventor
Hanna Bukowska
Marek Naruszewicz
Marie-Louise Johansson
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Publication of NO20000268L publication Critical patent/NO20000268L/no
Publication of NO20000268D0 publication Critical patent/NO20000268D0/no
Publication of NO324881B1 publication Critical patent/NO324881B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/856—Lactobacillus casei
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/857—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20000268A 1997-08-05 2000-01-19 Anvendelse av en stamme av Lactobacillus for fremstilling av et medikament for profylakse og/eller behandling av sirkulatoriske sykdommer. NO324881B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702860A SE510753C2 (sv) 1997-08-05 1997-08-05 Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
PCT/SE1998/001423 WO1999007827A1 (en) 1997-08-05 1998-07-30 Use of lactobacillus for reduction of the fibrinogen level in blood

Publications (3)

Publication Number Publication Date
NO20000268L NO20000268L (no) 2000-01-19
NO20000268D0 NO20000268D0 (no) 2000-01-19
NO324881B1 true NO324881B1 (no) 2007-12-27

Family

ID=20407874

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000268A NO324881B1 (no) 1997-08-05 2000-01-19 Anvendelse av en stamme av Lactobacillus for fremstilling av et medikament for profylakse og/eller behandling av sirkulatoriske sykdommer.

Country Status (19)

Country Link
US (1) US6214336B1 (de)
EP (1) EP0990024B1 (de)
JP (1) JP4651814B2 (de)
KR (1) KR100517755B1 (de)
CN (1) CN1142995C (de)
AR (1) AR016798A1 (de)
AT (1) ATE326524T1 (de)
AU (1) AU729413B2 (de)
BR (1) BR9811825A (de)
CA (1) CA2297023C (de)
DE (1) DE69834560T2 (de)
ES (1) ES2259457T3 (de)
IL (1) IL134113A0 (de)
NO (1) NO324881B1 (de)
NZ (1) NZ502610A (de)
PL (1) PL194697B1 (de)
SE (1) SE510753C2 (de)
WO (1) WO1999007827A1 (de)
ZA (1) ZA986769B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1117414A1 (de) 1998-10-01 2001-07-25 Probi Ab Reduktion von faktoren des oxidativen stresses
JP4193269B2 (ja) * 1999-03-04 2008-12-10 ビーエイチピーエイチ カンパニーリミテッド 新規な生体浄化活性型乳酸菌製剤
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
AUPR101600A0 (en) * 2000-10-25 2000-11-16 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
SE0004124D0 (sv) * 2000-11-10 2000-11-10 Probi Ab New use
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
KR20030033950A (ko) * 2001-10-20 2003-05-01 주식회사 알엔에이 유산균 세포질 분획물 또는 유산균 파쇄물을 유효성분으로포함하는 동맥경화 억제제
FR2831395B1 (fr) * 2001-10-25 2004-06-11 Triballat Laiteries Procede de fabrication de produits fermentes a base de soja, produits fermentes obtenus par ce procede et ferments correspondants
TWI241912B (en) * 2002-10-30 2005-10-21 Food Industry Res & Dev Inst Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
CN1207382C (zh) * 2003-04-11 2005-06-22 上海光明乳业股份有限公司 植物乳杆菌st－iii菌株及其在调节血脂方面的应用
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7001756B1 (en) * 2004-02-19 2006-02-21 Genmont Biotech Inc. Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity
GB0424552D0 (en) * 2004-11-05 2004-12-08 Cambridge Theranostics Ltd Methods and means
BRPI0611493B1 (pt) 2005-05-31 2022-04-05 Alimentary Health Ltd. Lactobacilos probióticos felinos
PL1885383T3 (pl) 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
US20080254011A1 (en) * 2007-04-11 2008-10-16 Peter Rothschild Use of selected lactic acid bacteria for reducing atherosclerosis
KR100909586B1 (ko) * 2007-06-01 2009-07-27 신현길 혈중 콜레스테롤 농도 저하에 효과적인 유산균 및 이들의혼합균주
SE532899C2 (sv) * 2007-06-08 2010-05-04 Probi Ab Förfarande genom fermentering med Lactobacillus plantarum för tillhandahållande av en insulinsvarsreducerande produkt och dess användning farmaceutiskt eller i livsmedel
JP5469873B2 (ja) * 2008-03-11 2014-04-16 株式会社日立製作所 回転電機
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
JP5140791B2 (ja) * 2008-11-27 2013-02-13 森下仁丹株式会社 乳酸菌含有血中ホモシステイン低減剤
WO2010096550A2 (en) 2009-02-18 2010-08-26 University Of Florida Research Foundation, Inc. Lactobacillus supplement for alleviating type 1 diabetes
ES2763137T3 (es) * 2009-06-19 2020-05-27 Dupont Nutrition Biosci Aps Bifidobacterias para el tratamiento de diabetes y afecciones relacionadas
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CN102031229B (zh) * 2009-09-24 2012-05-30 家医国际生化股份有限公司 具有肠胃道吸附能力及排除胆固醇能力的植物乳杆菌
US9056123B2 (en) * 2010-01-08 2015-06-16 Compagnie Gervais Danone Lactobacilli with anti-oxidant action
GB201319540D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition
GB201319538D0 (en) 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition
GB201709763D0 (en) 2017-06-19 2017-08-02 Probi Ab Biological materials and methods
CN110786435B (zh) * 2019-11-19 2022-08-23 四川农业大学 产高活性纤溶酶原激活剂的植物乳杆菌及用其发酵的果蔬汁饮料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0647551B2 (ja) * 1986-12-01 1994-06-22 株式会社ヤクルト本社 血圧降下剤
JP2676250B2 (ja) * 1989-03-20 1997-11-12 株式会社ヤクルト本社 血圧降下剤およびその製造法
JP2855290B2 (ja) * 1990-11-30 1999-02-10 株式会社ヤクルト本社 脂質代謝改善剤
JPH04264034A (ja) * 1991-02-18 1992-09-18 Snow Brand Milk Prod Co Ltd 生体内過酸化脂質抑制剤
JPH0525055A (ja) * 1991-07-22 1993-02-02 Yakult Honsha Co Ltd 血圧降下剤
SE469875C (sv) * 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
JPH06116155A (ja) * 1992-10-08 1994-04-26 Yakult Honsha Co Ltd 血清コレステロール低下剤
JP2801479B2 (ja) * 1992-10-09 1998-09-21 株式会社トクヤマ 補綴材料の製造方法
JP2992945B2 (ja) * 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌
JPH08208512A (ja) * 1995-02-03 1996-08-13 Nippon Chem Res Kk 血栓形成阻害剤

Also Published As

Publication number Publication date
US6214336B1 (en) 2001-04-10
EP0990024A1 (de) 2000-04-05
KR100517755B1 (ko) 2005-09-30
CA2297023A1 (en) 1999-02-18
SE9702860L (sv) 1999-02-06
SE9702860D0 (sv) 1997-08-05
KR20010022617A (ko) 2001-03-26
CN1265141A (zh) 2000-08-30
AU729413B2 (en) 2001-02-01
AR016798A1 (es) 2001-08-01
BR9811825A (pt) 2000-08-15
JP2001512747A (ja) 2001-08-28
ATE326524T1 (de) 2006-06-15
JP4651814B2 (ja) 2011-03-16
DE69834560T2 (de) 2006-11-02
IL134113A0 (en) 2001-04-30
PL194697B1 (pl) 2007-06-29
NO20000268L (no) 2000-01-19
EP0990024B1 (de) 2006-05-17
AU8372698A (en) 1999-03-01
ES2259457T3 (es) 2006-10-01
NO20000268D0 (no) 2000-01-19
CA2297023C (en) 2010-03-30
NZ502610A (en) 2000-12-22
WO1999007827A1 (en) 1999-02-18
SE510753C2 (sv) 1999-06-21
CN1142995C (zh) 2004-03-24
PL338578A1 (en) 2000-11-06
DE69834560D1 (de) 2006-06-22
ZA986769B (en) 1999-02-02

Similar Documents

Publication Publication Date Title
CA2297023C (en) Use of lactobacillus for reduction of the fibrinogen level in blood
US12370226B2 (en) Prevotella copri compositions
CN100421676C (zh) 乳酸产生细菌和肺功能
Cai et al. In vitro evaluation by PCA and AHP of potential antidiabetic properties of lactic acid bacteria isolated from traditional fermented food
CN104519895B (zh) 霞多丽种子产品的治疗用途
EP4185309A1 (de) Mikrobielle therapie
JP2018111711A (ja) リボフラビン、リン酸リボフラビン又は生理学上許容されるその塩
HATA et al. Clinical effects of brown seaweed, Undaria pinnatifida (wakame), on blood pressure in hypertensive subjects
NZ525657A (en) Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome
EA037388B1 (ru) Штамм lactobacillus paracasei для продуцирования линолевой кислоты с сопряженными связями, питательные и фармацевтические препараты, содержащие этот штамм, и их применение
AU2011314299B2 (en) Compositions and methods for augmenting kidney function
RU2671221C2 (ru) Композиции, содержащие смесь бактерий, включающую педиококк и лактобактерии, и способы для уменьшения эффектов алкоголя
KR20050010451A (ko) 비만증 또는 당뇨병 예방 및/또는 치료용 미생물
Oyetayo et al. Assessment of probiotic properties of a strain of Lactobacillus plantarum isolated from fermenting corn slurry (Ogi)
KR20010106068A (ko) 비만 또는 당뇨병 치료용 미생물 및 상기 미생물을포함하는 의약 조성물
UA65532C2 (uk) Дієтична композиція, що абсорбується, для поліпшення біологічного балансу флори кишкового тракту
KR20260074365A (ko) 혈관 내피 기능을 개선하기 위한 조성물
AU2024349207A1 (en) Composition for improving vascular endothelial function
Khiralla et al. The role of fermented soymilk with potential probiotic properties in the treatment of diarrhea in young rats
Matteuzzi et al. Growth kinetics on oligo-and polysaccharides and promising features of three antioxidative 2 potential probiotic strains 3
JP2023157809A (ja) 睡眠改善剤
Efrizal et al. The Effects of Rusip on the Amount of Lactic Acid Bacteria in Gastrointestinal Tract
Harnett Biochemical individuality; assessment of the chronic refractory (or complex) patient: Part two: Urinary metabolites originating from intestinal microbiota
Aumara et al. NUTRITIONAL, BIOLOGICAL AND HISTOLOGICAL EFFECTS OF ANTIOXIDATIVE PROBIOTIC PERMEATE BEVERAGE WITH LEMON JUICE
Aumara et al. PERMEATE BEVERAGE WITH

Legal Events

Date Code Title Description
MK1K Patent expired